← Leaderboards
Del D Miller
University Of Iowa
$3,040,977
Attributed
$3,040,977
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $479.1K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$3,040,977 · 6
By mechanism
U01$1,728,938 · 1
K23$825,418 · 1
P30$377,544 · 1
M01$109,077 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- Chadi A. Calarge$13,950,086
- Karin Weber-Gasparoni$4,014,781
- Jeffrey C Murray$40,323,548
- Jess G Fiedorowicz$868,963
- Antoine Bechara$6,578,305
Others in their field
Top investigators on “Schizophrenia”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$104,668,216
- Raquel E Gur · University Of Pennsylvania$60,189,770
- Mark J Daly · Broad Institute, Inc.$48,989,393
- John M Kane · Long Island Jewish Medical Center$45,235,871
- Carrie E Bearden · University Of California Los Angeles$42,025,230
- Scott W Woods · Yale University$41,221,536
Research focus
SchizophreniaClinical ResearchAntipsychotic AgentsHuman Therapy EvaluationHuman SubjectMental Disorder ChemotherapyClozapineRestRelapseRisperidoneDopamine ReceptorMicrospheresInnovationGenerationsPhysiciansPublic Health Medicine (Field)Adverse EffectsAtypical AntipsychoticPharmaceutical PreparationsOralEffectivenessDesignConsentRecording Of Previous Events
Grant awards (16)
Relapse Prevention: Long-Acting Atypical Antipsychotics$386,661
U01 · FY2010 · MH · contact PI
Relapse Prevention: Long-Acting Atypical Antipsychotics$451,167
U01 · FY2009 · MH · contact PI
Prediction of Relapse in Schizophrenia$240,975
U01 · FY2008 · MH · contact PI
Relapse Prevention: Long-Acting Atypical Antipsychotics$238,108
U01 · FY2008 · MH · contact PI
Relapse Prevention: Long-Acting Atypical Antipsychotics$204,094
U01 · FY2007 · MH · contact PI
RELAPSE PREVENTION: LONG-ACTING ATYPICAL ANTIPSYCHOTICS$137
M01 · FY2007 · RR · contact PI
Relapse Prevention: Long-Acting Atypical Antipsychotics$207,933
U01 · FY2006 · MH · contact PI
COMBINED RTMS AND CBT FOR REFRACTORY AUDITORY HALLUCINATIONS IN SCHIZOPHRENIA$52,609
M01 · FY2006 · RR · contact PI
COMBINED RTMS AND CBT FOR REFRACTORY AUDITORY HALLUCINATIONS IN SCHIZOPHRENIA$56,331
M01 · FY2005 · RR
ANTIPSYCHOTIC TREATMENT RESPONSE$165,844
K23 · FY2004 · MH
ANTIPSYCHOTIC TREATMENT RESPONSE$168,040
K23 · FY2003 · MH
ANTIPSYCHOTIC TREATMENT RESPONSE$166,845
K23 · FY2002 · MH
BASIC AND CLINICAL NEUROPHARMACOLOGY$266,433
P30 · FY2001 · MH
ANTIPSYCHOTIC TREATMENT RESPONSE$164,110
K23 · FY2001 · MH
ANTIPSYCHOTIC TREATMENT RESPONSE$160,579
K23 · FY2000 · MH
BASIC AND CLINICAL NEUROPHARMACOLOGY$111,111
P30 · FY2000 · MH